Dr. Michelle Farkas’ research involves studying cancer and the spread, or metastasizing of cancer. More specifically, it focuses largely on the relationship between circadian rhythms and aggression in cancer, the tracking of changes in macrophage subtype, and the creation of new systems that can be used to deliver nucleic acids and small molecule therapeutics with gold and fatty-acid nanoassemblies. Dr. Farkas is interested in discovering new ways to diagnose and treat cancer. During this presentation, Dr. Farkas mostly discussed the binding sites and markers necessary to treat cancer and the correlation that has been found between aggression in cancer and abnormal circadian rhythms. The results discussed proved a correlation between the two, however the exact molecular reason is unclear and is still being researched.
Recent comments